Issue 23, 2018

Oncosis-inducing cyclometalated iridium(iii) complexes

Abstract

Oncosis is a non-apoptotic form of programmed cell death (PCD), which differs from apoptosis in both morphological changes and inner pathways, and might hold the key to defeating a major obstacle in cancer therapy – drug-resistance, which is often a result of the intrinsic apoptosis resistance of tumours. However, despite the fact that the term “oncosis” was coined and used much earlier than apoptosis, little effort has been made to discover new drugs which can initiate this form of cell death, in comparison to drugs inducing apoptosis or any other type of PCD. So herein, we present the synthesis of a series of mitochondria-targeting cyclometalated Ir(III) complexes, which activated the oncosis-specific protein porimin and calpain in cisplatin-resistant cell line A549R, and determined their cytotoxicity against a wide range of drug-resistant cancer types. To the best of our knowledge, these complexes are the very first metallo-components to induce oncosis in drug-resistant cancer cells.

Graphical abstract: Oncosis-inducing cyclometalated iridium(iii) complexes

Supplementary files

Article information

Article type
Edge Article
Submitted
11 Mar 2018
Accepted
02 May 2018
First published
03 May 2018
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY-NC license

Chem. Sci., 2018,9, 5183-5190

Oncosis-inducing cyclometalated iridium(III) complexes

R. Guan, Y. Chen, L. Zeng, T. W. Rees, C. Jin, J. Huang, Z. Chen, L. Ji and H. Chao, Chem. Sci., 2018, 9, 5183 DOI: 10.1039/C8SC01142G

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements